Cercar
01/02/2024
Gluteal Hidradenitis Suppurativa: Analysis of 83 Patients
Riera-Martí, N, Vilarrasa, E, López-Llunell, C, Gamissans, M, Sin, M, Romaní, J. Gluteal Hidradenitis Suppurativa: Analysis of 83 Patients. Actas Dermo-Sifiliograficas. 2024; 115(2)DOI:10.1016/j.ad.2023.11.003. PMID:38048948. IF:(Q/D).
01/02/2024
New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis
Carmona-Rocha, E, Rusiñol, L, Puig, L. New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis. Pharmaceutics. 2024; 16(2)DOI:10.3390/pharmaceutics16020239. PMID:38399292. IF:5.500(Q1/1D).
06/01/2024
Painful flesh-coloured papules in a middle-aged woman
Carmona-Rocha, E, Rusiñol, L, Yélamos, O. Painful flesh-coloured papules in a middle-aged woman. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024; 49(6)DOI:10.1093/ced/llae007. PMID:38183665. IF:2.800(Q2/4D).
05/01/2024
Pustules, arthritis, and fever in a patient with Crohn's disease
Alturo-Pons, A, Carmona-Rocha, E, Rusiñol, L, Iznardo, H, Puig, L. Pustules, arthritis, and fever in a patient with Crohn's disease. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(6)DOI:10.1111/ijd.17003. PMID:38183159. IF:3.200(Q1/3D).
02/01/2024
Durability and long-term outcomes of biologic therapies in psoriasis
Rusinol, L, Carmona-Rocha E., Puig L.. Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology. 2024; 20(1)DOI:10.1080/1744666X.2023.2250918. PMID:37610817. IF:3.700(Q2/5D).
01/01/2024
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients
Manzanares N., Vilarrasa E., López A., Alonso M.L., Velasco M., Riera J., del Alcázar E., Carrascosa J.M., Azón A., Rivera R., Santos S., Salgado-Boquete L., Roncero M., Dorado M., Yelamos O., Delgado C., Gallardo F., Ferran M.. No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(1)DOI:10.1111/jdv.19406. PMID:37561934. IF:8.000(Q1/1D).
01/01/2024
Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis
Rusiñol, L, Puig, L. Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(2)DOI:10.3390/ijms25021042. PMID:38256115. IF:4.900(Q1/3D).
01/01/2024
Exposome and basal cell carcinoma: a multicenter case–control study
Navarro-Bielsa A., Gracia-Cazaña T., Almagro M., De-la-Fuente-Meira S., Florez Á., Yélamos O., Montero-Vilchez T., González-Cruz C., Diago A., Abadías-Granado I., Fuentelsaz V., Colmenero M., Bañuls J., Arias-Santiago S., Buendía-Eisman A., Almenara-Blasco M., Gil-Pallares P., Gilaberte Y.. Exposome and basal cell carcinoma: a multicenter case–control study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(7)DOI:10.1111/ijd.17026. PMID:38282244. IF:3.200(Q1/3D).
20/12/2023
Disseminated Monomorphic Pink Papules
Rusiñol, L, Mozos, A, Yélamos, O. Disseminated Monomorphic Pink Papules. JAMA Dermatology. 2023; 159(12)DOI:10.1001/jamadermatol.2023.3586. PMID:37938840. IF:11.500(Q1/1D).
18/12/2023
Price variability of TNF-a inhibitor biosimilars among European countries
Geat, D, Gisondi, P, Maurelli, M, Puig, L, Paul, C, Thaci, D, Iversen, L, Bellinato, F, Girolomoni, G. Price variability of TNF-a inhibitor biosimilars among European countries. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19756. PMID:38108512. IF:8.500(Q1/1D).
13/12/2023
Sodium metabisulfite a current low relevant allergen in Spain
Sanz-Sánchez, T, Giménez-Arnau, AM, Mercader-García, P, Perez, RG, Zaragoza-Ninet, V, Miquel-Miquel, J, Silvestre-Salvador, JF, Córdoba-Guijarro, S, Carrascosa-Carrillo, JM, Gática-Ortega, ME, Ruíz-Gonzalez, I, Tous-Romero, F, Ortiz-de Frutos, FJ, Serra-Baldrich, E, Pastor-Nieto, A, Rodríguez-Serna, M, Sánchez-Pérez, J, Gilo, AS, Melé-Ninot, G, Guillén, PSP, García-Doval, I, Borrego, L. Sodium metabisulfite a current low relevant allergen in Spain. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19702. PMID:38088580. IF:8.500(Q1/1D).
10/12/2023
An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis
Eyerich, K, Krueger, J, Stahle, M, Schakel, K, Conrad, C, Armstrong, A, Gniadecki, R, Puig, L, Scoble, T, Williams, N. An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19652. PMID:38071690. IF:8.500(Q1/1D).
01/12/2023
Melanoma-specific survival in worse in the elderly: a multicentric cohort study.
Segura S, Podlipnik S, Boada A, Martí RM, Sabat M, Yélamos O, Zarzoso-Muñoz I, Azón-Masoliver A, López-Castillo D, Solà J, Baliu-Piqué C, Galvany-Rossell L, Pasquali P, Just-Sarobé M, Duran X, Carrera C, Richarz NA, Pujol RM, Malvehy J, Puig S. Melanoma-specific survival in worse in the elderly: a multicentric cohort study.. MELANOMA RESEARCH. 2023; 33(6)DOI:10.1097/CMR.0000000000000923. PMID:37696262. IF:1.500(Q3/7D).
01/12/2023
Vitiligo-like hypopigmentation induced by dabrafenib-trametinib: a potential marker for clinical response
Carmona-Rocha, E, Sullivan, I, Yélamos, O. Vitiligo-like hypopigmentation induced by dabrafenib-trametinib: a potential marker for clinical response. MELANOMA RESEARCH. 2023; 33(6)DOI:10.1097/CMR.0000000000000918. PMID:37890183. IF:1.500(Q3/7D).
01/12/2023
High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome
Blanco, G, López-Aventín, D, Pujol, RM, Gómez-Llonín, A, Puiggros, A, López-Sánchez, M, Estrach, T, García-Muret, MP, López-Lerma, I, Servitje, O, Bellosillo, B, Muro, M, Espinet, B, Rabionet, R, Gallardo, F. High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome. JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2023; 37(23-24)DOI:10.1002/jcla.24982. PMID:38115685. IF:2.600(Q2/5D).
20/11/2023
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
Pereyra-Rodriguez, JJ, Baldrich, ES, Ruiz-Villaverde, R, Torres, EB, Dobao, PD, Nart, IF, Menéndez, AF, Martin-santiago, A, Miquel, JM, Silvestre, JF, Armario-Hita, JC. Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus. ACTA DERMATO-VENEREOLOGICA. 2023; 103DOI:10.2340/actadv.v103.12314. PMID:37982727. IF:3.500(Q1/3D).
14/11/2023
Non-invasive Skin Imaging in Cutaneous Lymphomas
Taleb, E, Yélamos, O, Ardigo, M, Christensen, RE, Geller, S. Non-invasive Skin Imaging in Cutaneous Lymphomas. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2023; 25(1)DOI:10.1007/s40257-023-00824-1. PMID:37964050. IF:8.600(Q1/1D).
06/11/2023
Yosipovitch, G, Lio, PA, Rosmarin, D, Serra-Baldrich, E, Legat, FJ, Casillas, M, Pierce, E, Liu, ZQ, Sun, LN, Elmaraghy, H, Ständer, S.
01/11/2023
First update of the living European guideline (EuroGuiDerm) on atopic eczema
Wollenberg A., Kinberger M., Arents B., Aszodi N., Barbarot S., Bieber T., Brough H.A., Pinton P.C., Christen-Zaech S., Deleuran M., Dittmann M., Fosse N., Gáspár K., Gerbens, LAA, Gieler U., Girolomoni G., Gregoriou S., Mortz C.G., Nast A., Nygaard U., Rehbinder E.M., Ring J., Rossi M., Roxburgh C., Serra-Baldrich E., Simon D., Szalai Z.Z., Szepietowski J.C., Torrelo A., Werfel T., Flohr C.. First update of the living European guideline (EuroGuiDerm) on atopic eczema. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(11)DOI:10.1111/jdv.19269. PMID:37328919. IF:8.500(Q1/1D).
01/11/2023
The Influence of the Exposome in the Cutaneous Squamous Cell Carcinoma, a Multicenter Case-Control Study
Navarro-Bielsa, A, Gracia-Cazaña, T, Almagro, M, de la Fuente-meira, S, Flórez, A, Yélamos, O, Montero-Vilchez, T, González-Cruz, C, Diago, A, Abadías-Granado, I, Fuentelsaz, V, Colmenero, M, Bañuls, J, Arias-Santiago, S, Buendía-Eisman, A, Almenara-Blasco, M, Gil-Pallares, P, Gilaberte, Y. The Influence of the Exposome in the Cutaneous Squamous Cell Carcinoma, a Multicenter Case-Control Study. Cancers. 2023; 15(22)DOI:10.3390/cancers15225376. PMID:38001636. IF:4.500(Q1/3D).
26/10/2023
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
Kwatra, SG, Yosipovitch, G, Legat, FJ, Reich, A, Paul, C, Simon, D, Naldi, L, Lynde, C, De Bruin-Weller, MS, Nahm, WK, Sauder, M, Gharib, R, Barbarot, S, Szepietowski, JC, Conrad, C, Fleischer, A, Laquer, VT, Misery, L, Serra-Baldrich, E, Lapeere, H, Ahmad, F, Lopez, ZKJ, Piketty, C, Ständer, S. Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis. NEW ENGLAND JOURNAL OF MEDICINE. 2023; 389(17)DOI:10.1056/NEJMoa2301333. PMID:37888917. IF:96.300(Q1/1D).
01/10/2023
The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.
Rivera-Díaz R, Pozo T, Alfageme F, Díaz Ley B, Osorio GF, Chico R, Vilarrasa E, Silvente C, Ciudad Blanco C, Romaní J, Martorell A, Fernández P, Romero Ferreiro C, Molina Leyva A. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.. Actas Dermo-Sifiliograficas. 2023; 114(9)DOI:10.1016/j.ad.2023.06.018. PMID:37479135. IF:(Q/D).
14/09/2023
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review
Girolomoni, G, Savage, L, Gisondi, P, Svensson, A, Mahe, E, Augustin, M, Puig, L. Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review. Dermatology and Therapy. 2023; DOI:10.1007/s13555-023-01014. PMID:. IF:3.500(Q1/3D).
01/09/2023
Statins and psoriasis: Position statement by the Psoriasis Task Force of the European Society of Dermatology and Venerology
Gonzalez-Cantero, A, Boehncke, WH, De Sutter, J, Zamorano, JL, Lambert, J, Puig, L. Statins and psoriasis: Position statement by the Psoriasis Task Force of the European Society of Dermatology and Venerology. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(9)DOI:10.1111/jdv.19191. PMID:37259959. IF:8.500(Q1/1D).
01/09/2023
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
Berenguer-Ruiz S., Aparicio-Domínguez M., Herranz-Pinto P., Ruíz-Villaverde R., López-Ferrer A., Santos-Juanes J., Rodríguez Fernández-Freire L., Hospital-Gil M., Arias-Santiago S., Carretero-Hernández G., Mateu-Puchades A., Ferran M., del Alcázar E., Santos-Alarcón S., Garcia-Latasa de Aranibar F.J., Belinchón-Romero I., González-Cantero Á., Ruíz-Genao D., Eiris-Salvado N., Rocamora-Durán V., Rivera-Diaz R., de la Cueva P., Daudén E., Salgado-Boquete L., Llamas-Velasco M.. Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19468. PMID:37625815. IF:8.500(Q1/1D).
01/09/2023
Epidermolysis bullosa acquisita induced by atezolizumab
Carmona-Rocha E., Aguado M., Tubau C., Sánchez S., Mozos A., Sullivan I., Spertino J.. Epidermolysis bullosa acquisita induced by atezolizumab. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023; DOI:10.1111/ddg.15203. PMID:37658659. IF:5.600(Q1/1D).
23/08/2023
Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium
Carmona-Rocha, E, Puig, L. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium. Immunotherapy. 2023; 15(15)DOI:10.2217/imt-2023-0013. PMID:37609785. IF:2.700(Q3/7D).
23/08/2023
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA)
Pereyra-Rodríguez J.J., Poveda J.L., Rivero A., Serra-Baldrich E., Silvestre J.F., Armario-Hita J.C., Calleja M.Á., Carrascosa J.M., Flórez Á., Herranz P., Comellas M., Ortiz de Frutos F.J.. Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA). JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19432. PMID:37594914. IF:8.500(Q1/1D).
04/08/2023
The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
Navarro-Compán V., Puig L., Vidal S., Ramírez J., Llamas-Velasco M., Fernández-Carballido C., Almodóvar R., Pinto J.A., Galíndez-Aguirregoikoa E., Zarco P., Joven B., Gratacós J., Juanola X., Blanco R., Arias-Santiago S., Sanz Sanz J., Queiro R., Canete, JD. The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1191782. PMID:37600764. IF:5.700(Q1/3D).
01/08/2023
Psoriasis: a focus on upcoming oral formulations
Rusinol, L, Carmona-Rocha E., Puig L.. Psoriasis: a focus on upcoming oral formulations. EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2023; 32(7)DOI:10.1080/13543784.2023.2242767. PMID:37507233. IF:4.900(Q1/2D).
12/07/2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population
Sahuquillo-Torralba A., Hospital-Gil M., Vilarrasa-Rull E., Llamas-Velasco M., Rivera R., Carrascosa J.M., de la Cueva-Dovao P., Armesto-Santos S., Ruíz-Villaverde R., Velasco-Pastor M., Magdaleno-Tapial J., Yanguas-Bayona J.I., Ribera-Pibernat M., Salgado-Boquete L., Herranz-Pinto P., Romero-Mate A., Martínez-Lorenzo E., López-Estebaranz J.L., Ballescá-López F., Botella-Estrada R.. Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2023; DOI:10.1111/ajd.14130. PMID:37435962. IF:2.200(Q2/5D).
03/07/2023
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Kirkham, BW, Egeberg, A, Behrens, F, Pinter, A, Merola, JF, Holzkaemper, T, Gallo, G, Ng, KJ, Bolce, R, Schuster, C, Nash, P, Puig, L. A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis. Rheumatology and Therapy. 2023; 10(5)DOI:10.1007/s40744-023-00553-1. PMID:37400681. IF:2.900(Q2/4D).
01/07/2023
Pradiktive Faktoren fur Anti-MDA5-Antikorper bei Patienten mit Dermatomyositis: eine retrospektive multizentrische Studie
Castellanos-Gonzalez, M, Bris, BB, Marsol, IB, Campos, MM, Ruiz-Villaverde, R, Llorente, CP, Nuno-Gonzalez, A, Sanchez, JT, Mur, EC, Garcia, RG, Alonso, AB, Espanol, GA, Garcia, YH, Schmidt, JMS, Sanchez, MA, Crespo, ER, Alonso, ED, Gallo-Pineda, G, Izquierdo, JAA, Varillas-Delgado, D. Pradiktive Faktoren fur Anti-MDA5-Antikorper bei Patienten mit Dermatomyositis: eine retrospektive multizentrische Studie. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023; 21(7)DOI:10.1111/ddg.15089_g. PMID:37427730. IF:5.600(Q1/1D).
01/07/2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study
Moreno-Arrones, OM, Bea-Ardebol, S, Mayo-Martinez, F, Perez-Pastor, G, Torres-Navarro, I, Bonfill-Orti, M, Deza, G, Ruiz-Salas, V, Masferrer, E, Feal, C, Turrion-Merino, L, Toll, A, Yebenes, M, Galiano-Mejias, S, Jaka, A, Ferrandiz-Pulido, C, Florez, A, Hernandez-Hernandez, N, Fernandez-de-Misa, R, Rios-Buceta, L, Sanmartin, O. Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study. Actas Dermo-Sifiliograficas. 2023; 114(7)DOI:10.1016/j.ad.2023.06.011. PMID:37302483. IF:(Q/D).
01/07/2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study.
Moreno-Arrones OM, Béa-Ardebol S, Mayo-Martinez F, Pérez-Pastor G, Torres-Navarro I, Bonfill-Ortí M, Deza G, Ruiz-Salas V, Masferrer E, Feal C, Turrión-Merino L, Toll A, Yébenes M, Galiano-Mejías S, Jaka A, Ferrandiz-Pulido C, Florez A, Hernández-Hernández N, Fernández-de-Misa R, Rios-Buceta L, Sanmartin O. Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study.. Actas Dermo-Sifiliograficas. 2023; 114(7)DOI:10.1016/j.ad.2023.04.022. PMID:37088285. IF:(Q/D).
21/06/2023
Dermoscopic features of trichoepithelioma: A multicentre observational case-control study conducted by the International Dermoscopy Society
Longo C., Lippolis N., Lai M., Spadafora M., Kaleci S., Condorelli A.G., Lombardi M., Pampena R., Argenziano G., Nazzaro G., Scalvenzi M., Akay B.N., Broganelli P., Fargnoli M.C., Paoli J., Yélamos O., Pellacani G., Borsari S., Lallas A.. Dermoscopic features of trichoepithelioma: A multicentre observational case-control study conducted by the International Dermoscopy Society. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(10)DOI:10.1111/jdv.19262. PMID:37326166. IF:8.500(Q1/1D).
13/06/2023
Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice
Costanzo A., Llamas-Velasco M., Fabbrocini G., Cuccia A., Rivera-Diaz R., Du Jardin, KG, Kasujee I., Puig L., Carrascosa J.M.. Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(10)DOI:10.1111/jdv.19229. PMID:37246505. IF:8.500(Q1/1D).
09/06/2023
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis
Zabotti, A, De Marco, G, Gosset, L, Baraliakos, X, Aletaha, D, Iagnocco, A, Gisondi, P, Balint, PV, Bertheussen, H, Boehncke, WH, Damjanov, NS, de Wit, M, Errichetti, E, Marzo-Ortega, H, Protopopov, M, Puig, L, Queiro, R, Ruscitti, P, Savage, L, Schett, G, Siebert, S, Stamm, TA, Studenic, P, Tinazzi, I, Van den Bosch, FE, van der Helm-van Mil, A, Watad, A, Smolen, JS, McGonagle, DG. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2023; 82(9)DOI:10.1136/ard-2023-224148. PMID:37295926. IF:20.300(Q1/1D).
01/06/2023
Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
Sanchez-Rodriguez, G, Puig, L. Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(12)DOI:10.3390/ijms241210305. PMID:37373452. IF:4.900(Q1/3D).
31/05/2023
Real-world experience with vismodegib on advanced and multiple BCCs: data from the RELIVIS study
Ruiz-Salas, V, Podlipnik, S, Sandoval-Clavijo, A, Sanmartin-Jimenez, O, Bernia-Petit, E, Bonfill-Orti, M, Bassas-Freixas, P, Yebenes-Marsal, M, Florez-Menendez, A, Sola-Ortigosa, J, Just-Sarobe, M, Aguayo-Ortiz, RS, Niubo, EMI, Quintana-Codina, M, Deza, G, Jaka, A, Fuentes, MJ, Canueto, J, Toll, A. Real-world experience with vismodegib on advanced and multiple BCCs: data from the RELIVIS study. DERMATOLOGY. 2023; 239(5)DOI:10.1159/000530813. PMID:37257423. IF:3.000(Q2/4D).
02/05/2023
A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer
Navarro-Bielsa A., Gracia-Cazaña T., Almagro M., De la Fuente-Meira, S, Florez Á., Yélamos O., Montero-Vilchez T., González-Cruz C., Diago A., Abadías-Granado I., Fuentelsaz V., Colmenero M., Banuls, J, Arias-Santiago S., Buendía-Eisman A., Almenara-Blasco M., Gil-Pallares P., Gilaberte Y.. A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE. 2023; 39(5)DOI:10.1111/phpp.12878. PMID:37130164. IF:2.500(Q2/4D).
01/05/2023
Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts
Carrascosa, JM, Vilarrasa, E, Belinchon, I, Herranz, P, Crespo, J, Guimera, F, Olveira, A. Common Approach to Metabolic-Associated Fatty Liver Disease in Patients With Psoriasis: Consensus-Based Recommendations From a Multidisciplinary Group of Experts. Actas Dermo-Sifiliograficas. 2023; 114(5)DOI:10.1016/j.ad.2023.01.004. PMID:36720362. IF:(Q/D).
20/04/2023
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey
Quirke-McFarlane, S, Weinman, J, Cook, ES, Yiu, ZZN, Dand, N, Langan, SM, Bechman, K, Tsakok, T, Mason, KJ, McAteer, H, Meynell, F, Coker, B, Vincent, A, Urmston, D, Vesty, A, Kelly, J, Lancelot, C, Moorhead, L, Barbosa, IA, Bachelez, H, Capon, F, Contreras, CR, De La Cruz, C, Di Meglio, P, Gisondi, P, Jullien, D, Lambert, J, Naldi, L, Puig, L, Spuls, P, Torres, T, Warren, RB, Waweru, H, Galloway, JB, Griffiths, CEM, Barker, JN, Norton, S, Smith, CH, Mahil, SK. Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey. BRITISH JOURNAL OF DERMATOLOGY. 2023; 188(5)DOI:10.1093/bjd/ljac144. PMID:36763806. IF:11.000(Q1/1D).
05/04/2023
Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale
Montero-Vilchez, T, Garces, JR, Rodriguez-Prieto, MA, Ruiz-Salas, V, de Eusebio-Murillo, E, Minano-Medrano, R, Escutia-Munoz, B, Gonzalez-Sixto, B, Artola-Igarza, JL, Alfaro-Rubio, A, Redondo, P, Delgado-Jimenez, Y, Sanchez-Schmidt, JM, Allende-Markixana, I, Alonso-Pacheco, ML, Garcia-Bracamonte, B, de la Cueva-dobao, P, Navarro-Tejedor, R, Ciudad-Blanco, C, Carnero-Gonzalez, L, Vazquez-Veiga, H, Cano-Martinez, N, Vilarrasa, E, Sanchez-Sambucety, P, Lopez-Estebaranz, JL, Botella-Estrada, R, Feal-Cortizas, JC, Martorell-Calatayud, A, Gil, P, Morales-Gordillo, V, Toll-Abello, A, Ocerin-Guerra, I, Mayor-Arenal, M, Suarez-Fernandez, R, Sainz-Gaspar, L, Descalzo, MA, Garcia-Doval, I, Sanmartin-Jimenez, O. Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(8)DOI:10.1111/jdv.19056. PMID:36950898. IF:8.500(Q1/1D).
01/04/2023
Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years
Falkenhain-Lopez, D, Muniesa, C, Estrach, MT, Morillo-Andujar, M, Penate, Y, Acebo, E, Pujol, RM, Garcia-Muret, MP, Machan, S, Medina, S, Botella-Estrada, R, de Misa, RF, Blanes, M, Florez, A, Perez-Paredes, G, Izu, R, Yanguas, I, Silva-Diaz, E, Perez-Ferriols, A, Prieto-Torres, L, Zayas, A, Parera-Amer, ME, Perez, A, Aspe, L, Roman, C, Sanchez-Caminero, MP, Bassas-Vila, J, Dominguez-Aunon, JD, Calzado, L, Navedo, M, Ortiz-Prieto, A, Servitje, O, Polo-Rodriguez, I, Torres, I, Hernandez-Hernandez, MN, Mitxelena-Eceiza, J, Garcia-Vazquez, A, Garcia-Doval, I, Ortiz-Romero, PL. Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years. Actas Dermo-Sifiliograficas. 2023; 114(4)DOI:10.1016/j.ad.2022.11.013. PMID:36848951. IF:(Q/D).
15/03/2023
Exploring the potential of artificial intelligence in improving skin lesion diagnosis in primary care
Escale-Besa, A, Yelamos, O, Vidal-Alaball, J, Fuster-Casanovas, A, Catalina, QM, Borve, A, Aguilar, RAE, Fusta-Novell, X, Cubiro, X, Rafat, ME, Lopez-Sanchez, C, Marin-Gomez, FX. Exploring the potential of artificial intelligence in improving skin lesion diagnosis in primary care. Scientific Reports. 2023; 13(1)DOI:10.1038/s41598-023-31340-1. PMID:36922556. IF:3.800(Q1/2D).
10/03/2023
Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes (vol 9, 1092688, 2023)
Egeberg A., Merola J.F., Schaekel, K, Puig L., Mahar P.D., Wang I.Y., Pavo I., Schuster C., Griffiths, CEM. Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes (vol 9, 1092688, 2023). Frontiers in Medicine. 2023; 10DOI:10.3389/fmed.2023.1171132. PMID:36974067. IF:3.100(Q1/2D).
22/02/2023
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials
Kokolakis, G, Warren, RB, Strober, B, Blauvelt, A, Puig, L, Morita, A, Gooderham, M, Korber, A, Vanvoorden, V, Wang, M, de Cuyper, D, Madden, C, Gomez, NN, Lebwohl, M. Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials. BRITISH JOURNAL OF DERMATOLOGY. 2023; 188(3)DOI:10.1093/bjd/ljac089. PMID:36751950. IF:11.000(Q1/1D).
01/02/2023
BAP1-inactivated Melanocytic Tumor: Dermoscopic Features to Aid Diagnosis
Fusta-Novell, X, Garcia-Herrera, A, Yelamos, O. BAP1-inactivated Melanocytic Tumor: Dermoscopic Features to Aid Diagnosis. Actas Dermo-Sifiliograficas. 2023; 114(2)DOI:10.1016/j.ad.2021.10.022. PMID:36216154. IF:(Q/D).
01/01/2023
Bimekizumab in the Treatment of Plaque Psoriasis Focus on Patient Selection and Perspectives
Camina-Conforto, G, Mateu-Arrom L., López-Ferrer A., Puig L.. Bimekizumab in the Treatment of Plaque Psoriasis Focus on Patient Selection and Perspectives. Patient Preference and Adherence. 2023; 17DOI:10.2147/PPA.S350760. PMID:37408843. IF:2.000(Q2/4D).
01/01/2023
Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain
Artime E., Serra E., Mert C., Díaz-Cerezo S., Huete T., Hernández-Subirá I., Lledo-Bryant L., Sicras-Mainar A.. Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain. Actas Dermo-Sifiliograficas. 2023; 114(1)DOI:10.1016/j.ad.2022.08.025. PMID:36368579. IF:(Q/D).
01/01/2023
Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial
Strober B., Paul C., Blauvelt A., Thaçi D., Puig L., Lebwohl M., White K., Vanvoorden V., Deherder D., Gomez N.N., Eyerich K.. Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2023; 89(3)DOI:10.1016/j.jaad.2023.04.063. PMID:37182701. IF:12.800(Q1/1D).
01/01/2023
PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries
Langenbruch A., Mohr N., Andrees V., Kessens I., Reich A., Czarnecka-Operacz M., Puig L., Dauden E., Iversen L., Augustin M.. PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries. ACTA DERMATO-VENEREOLOGICA. 2023; 103DOI:10.2340/actadv.v103.6532. PMID:37649411. IF:3.500(Q1/3D).
01/01/2023
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Pereyra-Rodríguez J.-J., Herranz P., Ruiz-Villaverde R., Elosua-González M., Galán-Gutiérrez M., Figueras-Nart I., Miquel J., de la Cueva P., Serra-Baldrich E., Munera-Campos M., Melé-Ninot G., Expósito-Serrano V., Perez B., Serrano A., Ortiz de Frutos J.F., Armario-Hita J.C.. Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2023; 48(9)DOI:10.1093/ced/llad153. PMID:37098171. IF:3.700(Q1/2D).
01/01/2023
Genetic and Epigenetic Mechanisms of Psoriasis
Mateu-Arrom L., Puig L.. Genetic and Epigenetic Mechanisms of Psoriasis. Genes. 2023; 14(8)DOI:10.3390/genes14081619. PMID:37628670. IF:2.800(Q2/5D).
01/01/2023
The biological basis of disease recurrence in psoriasis
Carmona-Rocha E., Puig L.. The biological basis of disease recurrence in psoriasis. Italian Journal of Dermatology and Venereology. 2023; 158(4)DOI:10.23736/S2784-8671.23.07583-7. PMID:37404193. IF:1.800(Q3/6D).
01/01/2023
Diversity in the clinical presentation of generalized pustular psoriasis (GPP): A series of case vignettes from around the world
Choon S.E., Elewski B.E., Fujita H., Geng S., van de Kerkhof P., Mburu S., Puig L., Romiti R., Venturini M.. Diversity in the clinical presentation of generalized pustular psoriasis (GPP): A series of case vignettes from around the world. EXPERIMENTAL DERMATOLOGY. 2023; 32(8)DOI:10.1111/exd.14794. PMID:36999936. IF:3.500(Q1/3D).
01/01/2023
Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter study
Castellanos-Gonzalez M., Bris B.B., Marsol I.B., Campos M.M., Ruiz-Villaverde R., Llorente C.P., Nuno-Gonzalez A., Sánchez J.T., Mur E.C., García R.G., Alonso A.B., Español G.A., García Y.H., Schmidt J.M.S., Sánchez M.A., Crespo E.R., Alonso E.D.L.H., Gallo-Pineda G., Izquierdo J.A.A., Varillas-Delgado D.. Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter study. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2023; 21(7)DOI:10.1111/ddg.15089. PMID:37218533. IF:5.600(Q1/1D).
01/01/2023
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study
Marti-Marti I., Podlipnik S., Cañueto J., Ferrándiz-Pulido C., Deza G., Sanmartín O., Jaka A., Beà-Ardèbol S., Botella-Estrada R., Redondo P., Turrión-Merino L., Ruiz-Salas V., Masferrer E., Yébenes M., Sánchez-Schmidt J.-M., Gracia-Darder I., Altemir-Vidal A., Aguayo-Ortiz R.S., Becerril S., Bodet-Castillo D., Leal L., Fuente M.J., Moreno-Arrones O.M., Abril-Pérez C., Tomás-Velázquez A., Sandoval-Clavijo A., Toll A.. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2023; 89(1)DOI:10.1016/j.jaad.2023.02.048. PMID:36907554. IF:12.800(Q1/1D).
01/01/2023
[Translated article] Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis [Actualización en el posicionamiento del Grupo Español de Psoriasis (GPS) en la utilización de medicamentos biosimilares en psoriasis moderada-grave]
Ruiz-Villaverde R., Galán-Gutiérrez M., Llamas-Velasco M., Salgado-Boquete L., Puig L., de la Cueva P., Carrascosa J.M.. [Translated article] Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis [Actualización en el posicionamiento del Grupo Español de Psoriasis (GPS) en la utilización de medicamentos biosimilares en psoriasis moderada-grave]. Actas Dermo-Sifiliograficas. 2023; 114(6)DOI:10.1016/j.ad.2023.02.022. PMID:37172891. IF:(Q/D).